34.231.21.105
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Infectious Diseases

FDA approves Vemlidy for chronic hepatitis B virus infection in pediatric patients

The U.S. Food and Drug Administration approved the supplemental new drug application for Vemlidy (tenofovir alafenamide) 25 mg tablets as a once-daily treatment for chronic hepatitis B virus (HBV) infection in pediatric patients ≥12 years of age with compensated liver disease, according to a press release. This approval was based...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-